Insulet | Zobowiązania



Current Liabilities Zmiana Data
Abbott USD 13B 1.15B 2025-03
Align Technology USD 1.99B 47.08M 2025-03
AtriCure USD 61.22M 12.2M 2025-03
Avanos Medical USD 165.9M 47M 2024-12
Baxter International USD 6.51B 311M 2024-12
Becton, Dickinson and Co. USD 7.66B 1.29B 2024-12
Boston Scientific USD 6.4B 489M 2024-12
Cardinal Health USD 35.22B 545M 2024-12
Cooper Companies USD 999.6M 23.2M 2025-01
Dexcom USD 2.93B 1.2B 2024-12
Edwards Lifesciences USD 1.51B 438.9M 2024-12
Eli Lilly USD 30.07B 1.69B 2025-03
Globus Medical USD 855.91M 37.85M 2024-12
ICU Medical USD 556.18M 6.62M 2024-12
Insulet USD 528.4M 22.2M 2024-12
Integra LifeSciences USD 922.13M 9.56M 2024-12
J&J USD 56.9B 6.58B 2025-03
Masimo USD 617.7M 19.9M 2024-12
Medtronic USD 11.84B 355M 2025-01
Merit Medical Systems USD 196.82M 19.58M 2025-03
Roche Holding CHF 27.02B 424M 2024-12
Solventum Corp 2.7B 201M 2024-12
Stryker USD 7.62B 53M 2024-12
Tandem Diabetes Care USD 288.18M 41.13M 2025-03
Teleflex USD 675.91M 26.55M 2025-03
West Pharmaceutical Services USD 526.7M 23.7M 2025-03
Zimmer Biomet Holdings USD 2.45B 1.12B 2024-12



Insulet Zobowiązania - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.